Hikari Bio has developed a novel technology for protein detection and quantification, CuTEDGE. By means of time-resolved fluorescence in the imaging step of gel-based proteomics, we can improve the sensitivity of detection 300-1000 fold over state-of-the-art methods, reaching single molecule detection.
Hikari Bio also develops eHealth tools and mobile Apps for home monitoring of post-acute sequelae of COVID-19 (PASC), a.k.a. post-COVID.
Company Details
- Employees
- 1
- Address
- Stockholm, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.hikaribio.se
- HQ
- Stockholm
Hikari Bio Questions
Hikari Bio's website is http://www.hikaribio.se
Hikari Bio's LinkedIn profile is https://se.linkedin.com/company/hikaribio
Hikari Bio has
1 employees.
View email and phone details for 1
employees at Hikari Bio.
Hikari Bio's industry is
Biotechnology Research
Hikari Bio's top competitors are
Navinci,
Life Science Invest,
Salipro Biotech Ab,
Atlas Antibodies,
Omixium,
Aax Biotech Ab,
Glucox Biotech,
Active Biotech Ab,
Pexa Ab,
Moleculent.
Hikari Bio's categories are Biotechnology Research
